Investigation of Hepatitis B and Hepatitis C in Taiwan
Information source: National Taiwan University Hospital
ClinicalTrials.gov processed this data on August 20, 2015
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Hepatitis B; Hepatitis C
Intervention: blood sampling and abdominal sonography (Biological)
Phase: N/A
Status: Completed
Sponsored by: National Taiwan University Hospital Official(s) and/or principal investigator(s):
Jin-Chuan Sheu, M.D. P.H.D., Study Chair, Affiliation: National Taiwan University Hospital
Summary
The purpose of this study is to investigate the differences of genotypes of hepatitis B and
hepatitis C in Taiwan.
Clinical Details
Official title: Investigation of Hepatitis B and Hepatitis C in Taiwan
Study design: Observational Model: Case-Only, Time Perspective: Cross-Sectional
Primary outcome: genotype and DNA level or RNA level of HBV and HCV virus
Detailed description:
The purpose of this study is investigating the differences of genotypes and DNA level or RNA
level of hepatitis B and hepatitis C in Taiwan.
Eligibility
Minimum age: 23 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Born before 1985/01/01
- HBV or HCV carriers
Exclusion Criteria:
- N/A
Locations and Contacts
National Taiwan University Hospital, Taipei 100, Taiwan
Additional Information
Starting date: April 2008
Last updated: January 20, 2011
|
